Apoptotic cell clearance by dendritic cells (DCs) plays a crucial role in the maintenance of self-tolerance. In spleen, CD8␣
I
t is vital to maintain self-tolerance so that an appropriate immune response to foreign organisms can be elicited without attacking normal body tissues. Self-tolerance within the T cell compartment is maintained in both central and peripheral lymphoid tissues. Self-Ags are presented by APCs in thymus, and T cells reactive to these self-Ags can be eliminated by apoptosis (1, 2) . Therefore, most self-reactive T cells do not appear in peripheral tissues; however, a small population of such cells still escapes thymic negative selection. In the periphery, tissue-resident dendritic cells (DCs) 4 constantly phagocytose apoptotic cells generated during normal tissue turnover and migrate to draining lymph nodes (LNs), where they present Ags derived from the apoptotic cells (3) (4) (5) . This presentation of self-Ags leads to deletion or anergy of any self-reactive T cells, thereby providing another mechanism to maintain T cell tolerance.
Phagocytes engulf apoptotic cells upon recognizing molecules on the surface of the corpses (6 -9) . One known "eat me" molecule is phosphatidylserine (PS). PS is normally located on the inner leaflet of plasma membrane bilayer of living cells, but when the cells undergo apoptosis, it is translocated to the outer leaflet. Several cell surface receptors or soluble proteins have been identified as PS-binding proteins for phagocytosis of apoptotic cells (10 -14) . Inhibition or absence of these molecular functions in vivo causes failure of apoptotic cell clearance and subsequent autoimmunity (13, 15, 16) . Findings of this sort clearly indicate that apoptotic cell clearance plays an important role in maintenance of self-tolerance.
Although it has been reported that apoptotic cells can be immunogenic under certain circumstances (17) (18) (19) , apoptotic cell death is believed to be tolerogenic in physiological conditions. Tolerance to cell-associated Ags by apoptotic cell clearance can be achieved by i.v. injection of apoptotic cells. When apoptotic cells loaded with an exogenous protein, OVA, were injected i.v. into mice, immune tolerance to OVA was induced in the animals (20) . Furthermore, several groups were able to control immune responses by i.v. injection of dying cells. Intravenous transfusion of apoptotic splenocytes from the donor strain prevented rejection of heart allografts (21) . Transfusion of apoptotic ␤ cells induced immune tolerance and subsequent suppression of diabetes in NOD mice (22) . We also reported that injection of apoptotic cells expressing the myelin oligodendrocyte glycoprotein (MOG) fragment suppressed the development of experimental autoimmune encephalomyelitis (EAE) (23) . Intravenous injection of apoptotic cells expressing a MOG fragment reduced MOG-specific T cell responses, whereas T cell responses to an irrelevant Ag were unaffected, indicating that tolerance to cell-associated Ags was specifically induced by apoptotic cell injection.
Intravenously injected apoptotic cells initially accumulate in the marginal zone (MZ) of spleen. These apoptotic cells are phagocytosed not only by macrophages located in MZ but also by splenic DCs. Among the DC subsets in spleen, CD8␣
ϩ DCs dominantly phagocytose injected apoptotic cells and present cell-associated Ags to T cells, suggesting that they are responsible for the tolerance induction to cell-associated Ags (24 -26) . However, as CD8␣
ϩ DCs are believed to be predominantly localized in the T cell zone (27, 28) , it remains to be determined how these DCs *Laboratory for Innate Cellular Immunity and phagocytose blood-borne apoptotic cells accumulated in the MZ. Recently, some CD8␣ ϩ DCs were found to be localized in MZ (29) , but it is still unclear whether there are any differences in phenotype and function between the CD8␣ ϩ DCs in the MZ and those in the T cell zone.
To elucidate the nature of the splenic CD8␣ ϩ DCs capable of phagocytosing apoptotic cells, we performed microarray analysis on these cells. We found that CD8␣
ϩ DCs in spleen consist of two subpopulations, CD103
ϩ ,CD207 ϩ DCs and CD103 Ϫ ,CD207
Ϫ DCs, and that the CD8␣ ϩ ,CD103 ϩ ,CD207 ϩ DCs played the dominant role in phagocytosis of blood-borne apoptotic cells. These cells were preferentially localized in the MZ and had potent activity in cross-presentation of cell-associated Ags. Transient ablation of CD8␣ ϩ ,CD103 ϩ ,CD207 ϩ DCs caused failure of tolerance induction to cell-associated Ags, indicating that this novel DC subset is responsible for tolerance induction by apoptotic cell clearance.
Materials and Methods

Mice
C57BL/6J mice and BALB/c mice were obtained from CLEA Japan. OT-I and OT-II mice were provided by Dr. W. R. Heath (Walter and Eliza Hall Institute, Melbourne, Australia). All mice were housed under specific pathogen-free conditions in the Research Center for Allergy and Immunology (RCAI) animal facility. All experiments using mice described herein were approved by the RCAI Animal Use Committee and performed in accordance with applicable guidelines and regulations.
Antibodies
Anti-CD8␣ (53-6.7), B220 (RA3-6B2), CD80 (16-10A1), CD86 (GL1), CD40 (3/23), CD103 (M290), H-2K b (AF6-88.5), and I-A b (AF6-120.1) Abs were obtained from BD Biosciences. Anti-CD207 (eBioL31) Ab was obtained from eBioscience. Anti-F4/80 Ab (6-16A) was provided by Dr. S. Nagata (Kyoto University, Kyoto, Japan). Anti-CD169 (3d6.112) Ab was obtained from Serotec. Anti-F4/80 and CD169 Abs were labeled by using the Alexa Fluor 488 mAb labeling kit (Molecular Probes).
Phagocytosis activity of DC subsets
To analyze phagocytic activity of apoptotic cells by DCs in vivo, W3 cells (mouse Fas-expressing WR19L cells) were labeled with 10 M CMFDA (Cell Tracker Green; Molecular Probes) for 30 min at 37°C. Apoptosis was induced by treatment with culture supernatant from Fas ligand-expressing cells in RPMI 1640 containing 1% syngeneic mouse serum for 4 h. The indicated numbers of apoptotic cells in 200 l of PBS were i.v. injected into mice through the tail vein. Spleens were obtained at various time points after the injection and flushed with 100 mU/ml collagenase D (Roche), teased apart with fine forceps, and digested with 400 mU/ml collagenase D for 15 min at 37°C. After digestion, splenic DCs were enriched by MACS sorting with anti-CD11c microbeads (Miltenyi Biotec). The splenic DCs were stained with allophycocyanin-labeled anti-CD8␣ Ab and/or PE-labeled anti-CD103 Ab and were analyzed by flow cytometry (FACSCalibur; BD Biosciences). Cells positive for CMFDA were considered to have engulfed injected apoptotic cells.
For the in vitro phagocytosis assay, splenic B cells were enriched with anti-B220 microbeads (Miltenyi Biotec) and were labeled with 0.5 M CMFDA. The cells were then cultured overnight after ␥ irradiation (6 Gy). 
Microarray analysis
CMFDA-labeled apoptotic W3 cells (2 ϫ 10 7 ) in 200 l of PBS/2.5% mouse serum were i.v. injected into C57BL/6J mice. Spleens were obtained 1 h after injection, and splenic DCs were enriched as described above. These cells were stained with PE-labeled anti-CD8␣ Ab and sorted by FACSVantage (BD Biosciences). Total RNA from three DC populations-1) CD8␣
ϩ ,CMFDA ϩ (phagocytosis of apoptotic cells), 2) CD8␣ ϩ , CMFDA Ϫ (nonphagocytosis of apoptotic cells), and 3) CD8␣ Ϫ -was isolated with TRIzol LS reagent (Invitrogen). Microarray experiments were performed using Mouse Genome 430 2.0 GeneChips (Affymetrix). GeneSpring GX 7.3.1 (Agilent) was used for data analysis. The intensity for each probe set was calculated using the MAS5 method of the GCOS software package (Affymetrix) at the default setting. Per chip normalization was performed using a median correction program in the GeneSpring software package (Agilent). The genes were selected on the basis of the following criteria: 1) genes that were annotated as plasma membrane proteins by the Mouse Genome Informatics (MGI) team at The Jackson Laboratory, 2) relative expression level ratio of CD8␣ 
Immunohistochemistry
Spleens were obtained from mice treated with or without CMFDA-labeled apoptotic cell injection. Cryosections (5 m) of the spleen were fixed in cold acetone and blocked with 1.5% normal goat serum and 2% Block Ace. Slides were incubated with biotinylated anti-CD207 Ab, followed by Cy3-streptavidin (Jackson ImmunoResearch Laboratories). For double staining, the slides were further incubated with Alexa488-labeled anti-F4/80, anti-CD169, or anti-B220 Abs. The sections were counterstained with 4Ј,6-diamidino-2-phenylindole, mounted with FluorSave (Calbiochem), and observed by fluorescence microscopy (BZ-8100; Keyence).
Ag presentation activity and cytokine production of DC subsets
W3/OVA cells were established as described previously (23 For analysis of cytokine production, CD8␣ ϩ ,CD103 ϩ DCs and CD8␣ ϩ ,CD103 Ϫ DCs were stimulated with LPS (Sigma-Aldrich), CpG DNA 1668 (synthesized by Hokkaido System Science), or poly(I:C) (Amersham Biosciences) for 48 h in vitro. The concentrations of IL-12 p40 and IL-6 in the culture medium were measured by ELISA (BD Biosciences) according to the manufacturer's protocols.
Tolerance induction to cell-associated OVA
OT-I T cells (1.7 ϫ 10 6 ) were injected into C57BL/6J mice. After 24 h, the mice were untreated or injected with 5 mg of horse cytochrome c (SigmaAldrich). One day later, 1 ϫ 10 7 apoptotic W3/OVA cells were injected i.v. into the mice. Seven days later, the mice were immunized with 50 g of OVA (Sigma-Aldrich) emulsified in CFA (Difco) in the footpads. Four days after immunization, popliteal and inguinal LNs were isolated, and CD8␣
ϩ T cells were enriched by cell sorting with anti-CD8␣ microbeads. 
Induction of EAE and apoptotic cell-mediated prevention of EAE
Induction of EAE and apoptotic cell-mediated prevention of EAE were described previously (23) . In brief, C57BL/6J mice were injected i.v. with 5 mg of cytochrome c or were untreated. Twenty-four hours later, the mice were injected i.v. with 2 ϫ 10 7 apoptotic W3/MOG-L cells or were untreated. Seven days later, the mice were immunized by s.c. administration at two sites in the tail-base of each mouse with 100 g of MOG peptide emulsified in CFA on day 0, supplemented with i.v. injection of 200 ng of pertussis toxin (Seikagaku) in PBS. Mice received an additional i.p. injection of 200 ng of pertussis toxin on day 2. The mice were observed for the presence of neurological signs of EAE and scored as follows: 0 ϭ no symptoms, 1 ϭ weak tail, 2 ϭ complete loss of tail tone, 3 ϭ ataxic gate, 4 ϭ hind leg paralysis, 5 ϭ hind and fore leg paralysis, and 6 ϭ death. Data are presented as mean clinical scores for each group.
Statistical analysis
All the statistical analyses were performed by using an unpaired two-tailed Student's t test. A value of p Ͻ 0.05 was considered significant.
FIGURE 2. Characterization of novel CD8␣
ϩ DC subset. A-C, Expression of CD103 and CD207 in splenic DCs of C57BL/6J and BALB/c mice. Splenic DCs were stained with CD8␣ and CD103 (A), CD8␣ and CD207 (B), or CD8␣, CD103, and CD207 (C). C, The surface expression of CD103 and CD207 on CD8␣ 
Results
Subpopulation of CD8␣ ϩ DCs phagocytoses circulating apoptotic cells in spleen
Splenic conventional DCs consist of CD8␣ ϩ and CD8␣ Ϫ subpopulations and i.v. injected apoptotic cells are predominantly phagocytosed by the CD8␣ ϩ cells (Fig. 1A) . We injected various numbers of fluorescence-labeled apoptotic cells into mice and found that only a subset of splenic CD8␣ ϩ DCs could phagocytose the cells. As shown in Fig. 1B , only ϳ50% of CD8␣ ϩ DCs engulfed apoptotic cells, even when a very large number (10 8 ) of apoptotic cells were injected. These results suggest the existence of a subpopulation of CD8␣ ϩ DCs specializing in the uptake of apoptotic cells.
To characterize these phagocytic CD8␣ ϩ DCs, we injected mice with fluorescence-labeled apoptotic cells and then isolated CD8␣ ϩ phagocytic and nonphagocytic DCs by cell sorting and compared their gene expression profiles by DNA microarray. A number of genes were expressed differentially between the two cell populations, but we focused here on cell surface molecules. As shown in Fig. 1C, CD8␣ ϩ DCs phagocytosing apoptotic cells differentially expressed higher mRNA levels of several cell surface molecules.
Next, we examined the surface expression of some of these molecules on splenic DCs and found that the level of integrin ␣ E (Itgae), also known as CD103, varied among the CD8␣ ϩ DCs, separating them into two distinct subpopulations ( Fig.  2A) . We could detect surface CD103 expression on only ϳ50% of CD8␣
ϩ DCs in C57BL/6J mice. We also tested the surface expression of langerin, also known as CD207. CD207 was undetectable on splenic DCs from C57BL/6J mice (Fig. 2B) . However, in BALB/c mice, whose DCs express CD207 more abundantly than those in C57BL/6J mice (30), we detected langerin expression on a subset of CD8␣ ϩ DCs. Double staining with CD103 and CD207 revealed that almost all CD103
ϩ DCs expressed CD207 on their surfaces (Fig. 2C) Ϫ DCs (Fig. 2D) , clearly indicating that the CD8␣ ϩ , CD103
ϩ DC subset specializes in the clearance of circulating apoptotic cells.
We also compared the expression patterns of several other surface molecules on DCs. As shown in Fig. 2E , the expression of CD40, CD80, MHC class I, and MHC class II was the same in the two subpopulations, whereas the surface expression of CD86 was slightly higher in the CD103 ϩ DC subpopulation. We again performed gene expression analysis of CD8␣ ϩ , CD103
ϩ DCs and CD8␣ ϩ ,CD103 Ϫ DCs without injection of apoptotic cells and confirmed that CD103 and CD207 mRNA expression levels were much higher in the CD8␣ ϩ ,CD103 ϩ DCs than in CD8␣ ϩ ,CD103 Ϫ DCs (Fig. 2F) . However, we found that the expression of some of the genes listed in Fig. 1C , including CD80 and Tnfsf9, was similar in the two subpopulations, suggesting that these genes were up-regulated in CD8␣
ϩ ,CD103 ϩ DCs in response to phagocytosis of apoptotic cells. 
CD8␣
ϩ DCs are reported to be localized in both the T cell zone and the MZ of spleen (27) (28) (29) ; therefore, we examined the localization of the novel DC subset. Because CD207 is exclusively expressed by the DC population, whereas CD103 is also expressed by some T cells, we performed immunohistochemical analysis with an anti-CD207 Ab. As shown in Fig. 3A , CD207 immunoreactivity was predominantly detected in the splenic MZ, whereas a relatively small number of these DCs were also found in red pulp
ϩ marginal metallophilic macrophages (MMMs) in the MZ (Fig. 3B) . When apoptotic cells were injected i.v. into mice, they initially accumulated in the MZ. We detected fluorescence-labeled apoptotic cells within CD207
ϩ cells 1 h after injection (Fig. 3, C and D) . These results indicate that the CD8␣ ϩ , CD103 ϩ ,CD207 ϩ DCs phagocytosed circulating apoptotic cells in the MZ.
It has been reported that DCs migrate to the T cell zone by various stimuli (31) (32) (33) . We next examined whether the localization of the DC subset changed after apoptotic cell phagocytosis. Apoptotic cells were i.v. injected into mice. CD207 immunoreactivity was mainly detected in the MZ until 6 h after injection of apoptotic cells (data not shown), but by 12 h, most of the CD207 ϩ cells were found in the T cell zone (Fig. 4) . These results suggest that this DC subset migrates from the MZ into the T cell zone after phagocytosis of apoptotic cells.
Functional differences between the two CD8␣
ϩ DC subpopulations Differences in cell surface marker and localization suggest that the two CD8␣
ϩ DC subpopulations have distinct functions. We first examined apoptotic cell phagocytic activity of the two CD8␣ ϩ DC subpopulations in vitro. Fluorescence-labeled apoptotic cells were cocultured with CD11c ϩ DCs, and these cells were analyzed by flow cytometry. As shown in Fig. 5A , a larger percentage of CD8␣ ϩ ,CD103 ϩ DCs phagocytosed apoptotic cells than did the CD8␣ ϩ ,CD103 Ϫ DCs. We also performed phagocytosis assay with bacteria and latex beads and found that CD8␣ ϩ ,CD103 Ϫ DCs phagocytosed these particles as efficiently as CD8␣ ϩ ,CD103 ϩ FIGURE 4. Migration of CD8␣ ϩ ,CD103 ϩ ,CD207 ϩ DCs into the T cell zone after apoptotic cell phagocytosis. Apoptotic W3 cells were injected i.v. into mice. Spleens were obtained 12 h after injection (right panels), and cryosections were stained with CD207 and CD169 (upper panels) or with CD207 and B220 (lower panels). Scale bar, 100 m. 
DCs. These results indicate that the CD8␣
ϩ ,CD103 ϩ DCs possess potent intrinsic activity for apoptotic cell phagocytosis. We next examined the Ag presentation capacity of the two CD8␣ ϩ DC subpopulations. First, we performed an in vitro assay by simply adding peptides to cocultures with OT-I cells or OT-II cells from OVA-specific TCR transgenic mice. Both CD8␣ ϩ ,CD103 ϩ DCs and CD8␣ ϩ ,CD103 Ϫ DCs stimulated proliferation of OT-I and OT-II cells (Fig. S1) , 5 indicating that both DC subpopulations were capable of Ag presentation. Next, we analyzed the presentation activity of cell-associated Ags. Apoptotic W3 cells expressing OVA (W3/OVA cells) were injected i.v. into mice. Three hours after injection, CD8␣ ϩ ,CD103 ϩ and CD8␣ ϩ ,CD103 Ϫ DCs were isolated from spleens and cocultured with OT-I cells from OVAspecific TCR transgenic mice. Consistent with their ability to phagocytose apoptotic cells in vivo, CD8␣ ϩ ,CD103 ϩ DCs exhibited strong presentation activity of cell-associated OVA to CD8 T cells, whereas CD8␣ ϩ ,CD103 Ϫ DCs hardly induced any proliferation of these T cells (Fig. 5B) . We also examined the presentation activity of cell-associated Ags to OT-II cells after phagocytosis of apoptotic cells; however, no significant proliferation was induced 5 The online version of this article contains supplemental material. 
TOLERANCE INDUCTION BY A NOVEL CD8␣
ϩ DC SUBSET by the novel CD8␣ ϩ DC subset (data not shown). We next tested ability of these subpopulations to present soluble Ag. When soluble OVA was injected i.v., it was taken up to some extent by both CD8␣ ϩ ,CD103 ϩ and CD8␣ ϩ ,CD103 Ϫ DCs (data not shown). Three hours after injection, these DCs were cocultured with OT-I and OT-II cells. As shown in Fig. 5C , the Ag presentation activity of CD8␣ ϩ ,CD103 ϩ DCs to OT-I cells was much stronger than that of CD8␣ ϩ ,CD103 Ϫ DCs, even though these two subpopulations equally stimulated the proliferation of OT-II cells. These results indicate that CD8␣ ϩ ,CD103 ϩ DCs have stronger cross-presentation activity for both cell-associated and soluble Ags.
We also analyzed the differences in cytokine production by the two DC subpopulations, which were isolated from spleen, and stimulated with CpG, LPS, poly(I:C), or apoptotic cells in vitro. CpG stimulation induced production of IL-12 p40 in both subpopulations; however, the CD8␣ ϩ ,CD103 ϩ DCs produced a larger amount than the CD8␣ ϩ ,CD103 Ϫ DCs (Fig. 5D ). LPS and poly(I:C) also stimulated IL-12 p40 production by these DC subpopulations, and although they were less effective than CpG, the amount of cytokine produced was greater in CD8␣ ϩ ,CD103 ϩ DCs than in CD8␣ ϩ ,CD103 Ϫ DCs. Coculture of apoptotic cells did not enhance cytokine production. CpG also stimulated IL-6 production in the two subpopulations (Fig. 5E ), but in contrast to the situation with IL-12, CD8␣ ϩ ,CD103 Ϫ DCs produced a larger amount of IL-6 than CD8␣ ϩ ,CD103 ϩ DCs. Taken together, these results clearly indicate that the two CD8␣ ϩ DC subpopulations have distinct cytokine profiles upon stimulation with TLR ligands.
Stimulation with TLR ligands induces disappearance of the CD8␣
ϩ ,CD103 ϩ DC subset in vivo TLR signals exert a variety of effects on DC function and play a critical role in the regulation of immune responses (34, 35) . Furthermore, it is recently reported that systemic exposure to TLR ligands impairs cross-presentation activity of DCs (36) . Therefore, we examined the effects of TLR ligands on the DC subpopulations in vivo. LPS or poly(I:C) was injected into mice, and splenic DCs were analyzed by flow cytometry. As shown in Fig. 6A , the number of CD8␣ ϩ ,CD103 ϩ DCs was drastically reduced 24 h after injection. The CD8␣ ϩ ,CD103 ϩ DCs remained absent for 3 or 4 days, but the subset was eventually restored by day 7 after injection of these ligands (Fig. S2). On the other hand, CD8␣ ϩ , CD103 Ϫ DCs were unaffected by injection of TLR ligands (Fig.  6A) , strongly suggesting that there was no conversion of CD8␣ ϩ , CD103
ϩ DCs into CD8␣ ϩ ,CD103 Ϫ DCs upon TLR ligand stimulation. We also tested the effects of LPS and poly(I:C) on CD103 expression by DCs in vitro and found that the population of CD8␣ ϩ , CD103 ϩ DCs was unchanged by stimulation for 24 h with these TLR ligands (Fig. 6B) . These results suggest that TLR stimulation neither induces down-regulation of CD103 nor cell death exclusively in the CD8␣ ϩ ,CD103 ϩ DC subpopulation at least in vitro. However, these results cannot deny the possibility that TLR stimulation selectively kills CD8␣ ϩ ,CD103 ϩ DCs in vivo. We next examined the effects of TLR ligand treatment on phagocytosis of injected apoptotic cells by DCs. LPS or poly(I:C) was injected into mice, and 24 h later, fluorescence-labeled apoptotic cells were injected i.v. into the mice. In accordance with the disappearance of CD8␣ ϩ ,CD103 ϩ DCs, the CD8␣ ϩ DCs in mice treated with TLR ligands no longer phagocytosed injected apoptotic cells (Fig. 6C) . Immunohistochemical analysis revealed that injected apoptotic cells still accumulated in the MZ of mice treated with LPS, whereas no CD207 ϩ cells were detected there (Fig. 6D) . Consistent with the absence of apoptotic cell phagocytosis by CD8␣
ϩ DCs, CD8␣ ϩ DCs no longer showed cross-presentation activity of cell-associated OVA Ags after i.v. injection of W3/ OVA cells in mice treated with either TLR ligand (Fig. 6E) . Taken together, these results suggest that the disappearance of CD8␣ ϩ , CD103
ϩ DCs is, at least in part, involved in TLR stimulationinduced immune regulation.
Impairment of tolerance induction to cell-associated Ags in the absence of CD8␣
ϩ ,CD103 ϩ DC subset Apoptotic cell clearance by phagocytes is crucial for maintenance of self-tolerance. Therefore, we determined the roles of CD8␣ ϩ , CD103
ϩ DCs in tolerance induction to cell-associated Ags. It was recently reported that i.v. injection of cytochrome c induced apoptotic cell death in certain CD8␣
ϩ DCs (37). We carefully examined this phenomenon and found that CD8␣ ϩ ,CD103 ϩ DCs were selectively deleted in vivo by cytochrome c treatment. As shown in Fig. 7A , cytochrome c injection resulted in a reduction in the number of CD8␣ ϩ ,CD103 ϩ DCs in spleen, whereas the population of CD8␣ ϩ ,CD103 Ϫ DCs was unaffected. Consistent with the reduced number of CD8␣ ϩ ,CD103 ϩ DCs, phagocytosis of injected apoptotic cells by CD8␣
ϩ DCs was severely impaired in cytochrome c-treated mice (Fig. 7B) . On the basis of these observations, we tested tolerance induction to cell-associated Ags induced by apoptotic cell injection in mice treated with cytochrome c. We first examined tolerance induction in OVA-specific T cells by injection of OVA-expressing apoptotic cells into C57BL/6J mice that had received OT-I cells 24 h previously. In control mice, i.v. injection of apoptotic W3/OVA cells caused hyporesponsiveness of OT-I cells to subsequent immunization with OVA/CFA (Figs. 7C and  S3 ). By contrast, the OT-I responses were not reduced by injection of apoptotic W3/OVA cells in mice treated with cytochrome c. We also examined our previously reported model of apoptotic cellmediated prevention of EAE (23) . In control mice, injection of apoptotic cells expressing MOG fragment (W3/MOG-L cells) prevented progression of EAE induced by immunization with MOG peptide/CFA (Fig. 7D) , but the suppressive effects of apoptotic W3/MOG-L cells were largely eliminated when the mice were treated with cytochrome c. Taken together, these results indicate that CD8␣
ϩ ,CD103 ϩ DCs play a critical role in tolerance induction to cell-associated Ags by phagocytosis of blood-borne apoptotic cells.
Discussion
The splenic MZ is a special site where various types of bloodborne Ags are trapped and cleared (38, 39) . Circulating apoptotic cells are trapped in the MZ as well and are rapidly cleared by two types of macrophages, marginal zone macrophages (MZMs) and MMMs. In the absence of these macrophages, the clearance of apoptotic cells is significantly delayed (23) . In addition to macrophages, CD8␣
ϩ DCs phagocytose apoptotic cells and present cellassociated Ags to T cells (20, 24 -26) . In the present study, we showed that the CD8␣ ϩ DC population in spleen consisted of at least two subpopulations, CD103 ϩ ,CD207 ϩ DCs and CD103 Ϫ , CD207
Ϫ DCs. The CD8␣ ϩ ,CD103 ϩ DC subpopulation is mainly located in the MZ and is responsible for uptake of circulating apoptotic cells. Studies involving the selective deletion of CD8␣ ϩ , CD103
ϩ DCs clearly indicate that this subset is important in tolerance induction to cell-associated Ags.
Cross-presentation of Ags by DCs plays a critical role in immune responses to viruses and tumors (4, 40) , and CD8␣
ϩ DCs are thought to have a unique capacity for cross-presentation in spleen (25) . Our study demonstrated that the CD8␣ ϩ ,CD103 ϩ DC subpopulation is more important for cross-presentation than the CD8␣ ϩ ,CD103 Ϫ DC subpopulation. In addition to their cross-presentation activity, the CD8␣ ϩ ,CD103 ϩ ,CD103 ϩ DCs should be explored to better understand the roles of these cells. CD8␣ Ϫ DCs are also present in the splenic MZ (28), and they exhibit phagocytic activity for apoptotic cells under certain circumstances (23) . In contrast, the CD8␣ ϩ ,CD103 ϩ DCs are the predominant cell type involved in phagocytosis of apoptotic cells under physiological conditions. It is a challenge to elucidate the mechanisms underlying the dominance of CD8␣ ϩ ,CD103 ϩ DCs over CD8␣
Ϫ DCs in phagocytosing apoptotic cells that accumulate in the MZ. In addition to the immune reaction to cell-associated Ags, CD8␣
ϩ DCs also play an important role in facilitating efficient entry of Listeria monocytogenes into the spleen as well as the subsequent immune responses to these organisms (29) . Because blood-borne L. monocytogenes initially appear in the MZ, the CD8␣ ϩ ,CD103 ϩ DC subset may be involved in its entry into spleen. It will be important to analyze the roles of these DCs in the entry and the subsequent immune reaction to blood-borne microorganisms.
DC subpopulations expressing CD103 were recently found in various organs, including lung and intestine (41) (42) (43) . However, the roles of these cells have not been fully elucidated. It was recently reported that a fraction of CD11c ϩ DCs in colonic lamina propria and mesenteric LNs expressed CD103 and that these DCs could induce generation of regulatory T cells in vitro (44) , suggesting that these cells contribute to tolerance induction to Ags administered orally. In the present study, we found that CD8␣ ϩ , CD103
ϩ DCs in spleen could phagocytose apoptotic cells and are responsible for tolerance induction to cell-associated Ags injected i.v. These findings suggest that CD103
ϩ DCs in various organs share the common feature of being tolerogenic. Xia et al. (22) reported that i.v. injection of UV-irradiated cells induced production of immunosuppressive regulatory T cells. It will be interesting to examine whether CD8␣ ϩ ,CD103 ϩ DCs in spleen also have the ability to induce regulatory T cells when they phagocytose apoptotic cells. The integrin ␣ E chain forms a heterodimer with the integrin ␤ 7 chain. The principal ligand of ␣ E ␤ 7 is E-cadherin, an epithelial homophilic adhesion molecule, although there are suggestions that this integrin may bind another unidentified ligand (45) (46) (47) . The majority of intestinal intraepithelial lymphocytes and some lamina propria T lymphocytes express ␣ E ␤ 7 integrin (48, 49) . The number of these T cells was significantly reduced in CD103-deficient mice, suggesting that it plays a critical role in the generation and/or localization of these T lymphocytes (50) . The role of CD103 in T cells has also been demonstrated under pathological conditions. Suffia et al. (51) reported that CD103 is expressed by a subset of regulatory T cells and plays a critical role in the retention of Treg cells in the Leishmania major infection site. CD103 expression is also required to retain donor-derived host-specific CD8 T cells in the host intestinal epithelium in a graft-vs-host disease model (52) . These findings strongly suggest that CD103 acts as a tethering molecule for T cells to ensure their localization in specific sites under physiological and pathological conditions. In the present study, we showed that CD103-expressing DCs preferentially localize in the MZ of spleen. Taking the roles of CD103 on T cells into consideration, CD103 may play a role in the retention of these DCs in the MZ. It will be of considerable interest to reveal the mechanisms underlying the regulation of CD103 expression in DCs.
In this study, administration of TLR ligands resulted in the disappearance of the CD8␣ ϩ ,CD103 ϩ DC subset in spleen. Consistent with the disappearance of this subset, CD8␣
ϩ DCs failed to phagocytose injected apoptotic cells. It was recently reported that systemic exposure to TLR ligands impairs cross-presentation activity of DCs and antiviral immunity (36) ; however, the underlying mechanisms have not been revealed. Our findings suggest that disappearance of the CD8␣ ϩ ,CD103 ϩ DC subset may be, at least in part, one of the mechanisms for failure of cross-presentation upon stimulation with TLR ligands. We have not discovered how this DC subset disappears following TLR stimulation in vivo. In general, TLR stimulation induces the maturation of DCs. However, we doubt that CD103 expression on these DCs is down-regulated during maturation upon stimulation with TLR ligands because 1) the population of CD8␣ ϩ ,CD103 Ϫ DCs did not increase upon TLR stimulation, suggesting that the CD103 ϩ DCs did not convert into CD103 Ϫ cells, and 2) in vitro stimulation with TLR ligands did not change the expression levels of CD103 on isolated DCs. We observed that injection of LPS induced structural changes in the MZ. Therefore, CD8␣
ϩ ,CD103 ϩ DCs might not be able to localize in the MZ due to lack of tethering molecules, e.g., an integrin ligand. In any case, it should be informative to analyze the dynamics of CD8␣ ϩ ,CD103 ϩ DCs upon stimulation with TLR ligands in vivo. In summary, we have identified a novel subpopulation of splenic CD8␣
ϩ DCs specializing in the uptake of apoptotic cells and in subsequent tolerance induction to cell-associated Ags. Further studies are needed to explore the features of the CD8␣ ϩ , CD103 ϩ ,CD207 ϩ DCs that are important for the maintenance of self-tolerance.
